The changes of liver stiffness and its associated factors for chronic hepatitis B patients with entecavir therapy

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Kuo, Yuan Hung ^a   Lu, Sheng Nan ^a   Chen, Chien Hung ^a   Chang, Kuo Chin ^a   Hung, Chao Hung ^a   Tai, Wei Chen ^a   Tsai, Ming Chao ^a   Tseng, Po Lin ^a   Hu, Tsung Hui ^a   Wang, Jing Houng ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; ENTECAVIR; ANTIVIRUS AGENT; GUANINE; HEPATITIS B(E) ANTIGEN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD SAMPLING; CHRONIC DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ECHOGRAPHY; ELASTOGRAPHY; FEMALE; FOLLOW UP; HEPATITIS B; HUMAN; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; RETROSPECTIVE STUDY; RIGIDITY; RISK FACTOR; TREATMENT DURATION; TREATMENT OUTCOME; ANALOGS AND DERIVATIVES; BLOOD; DRUG EFFECTS; HEPATITIS B, CHRONIC; LIVER; METABOLISM; MIDDLE AGED; PATHOLOGY;

ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; ASPARTATE AMINOTRANSFERASES; FEMALE; GUANINE; HEPATITIS B E ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84899861065     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0093160     Document Type: Article

References (30)

1. McMahon BJ (2009) The natural history of chronic hepatitis B virus infection. Hepatology 49(5 Suppl): S45-55.
2. Ganem D, Prince AM (2004) Hepatitis B virus infection - natural history and clinical consequences. N Engl J Med 350(11):1118-1129.
3. Benvegnu L, Gios M, Boccato S, Alberti A (2004) Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications. Gut 53:744-749.
4. Chang TT, Liaw YF, Wu SS, Schiff E, Han KH, et al. (2010) Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B. Hepatology 52(3):886-893.
5. Yuen MF, Chow DH, Tsui K, Wong BC, Yuen JC, et al. (2005) Liver histology of Asian patients with chronic hepatitis B on prolonged lamivudine therapy. Aliment Pharmacol Ther 21(7): 841-849.
6. Liaw YF, Sung JJ, Chow WC, Farrell G, Lee CZ, et al. (2004) Lamivudine for patients with chronic hepatitis B and advanced liver disease. Cirrhosis Asian Lamivudine Multicentre Study Group. N Engl J Med. 351(15):1521-1531.
7. Bravo AA, Sheth SG, Chopra S (2001) Liver biopsy. N Engl J Med 344:495-500.
8. Maharaj B, Maharaj RJ, Leary WP, Cooppan RM, Naran AD, et al. (1986) Sampling variability and the influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1:523-525.
9. Regev A, Berho M, Jeffers LJ, Milikowski C, Molina EG, et al. (2002) Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 97:2614-2618.
10. Friedrich-Rust M, Ong MF, Martens S, Sarrazin C, Bojunga J, et al. (2008) Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 134(4): 960-974.
11. Corpechot C, El Naggar A, Poujol-Robert A, Ziol M, Wendum D, et al. (2006) Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. Hepatology 43(5): 1118-1124.
12. Marcellin P, Ziol M, Bedossa P, Douvin C, Poupon R, et al. (2009) Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int 29(2): 242-247.
13. Castera L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, et al. (2005) Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 128(2): 343-350.
14. Foucher J, Chanteloup E, Vergniol J, Castéra L, Le Bail B, et al. (2006) Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 55(3): 403-408.
15. Fraquelli M, Rigamonti C, Casazza G, Conte D, Donato MF, et al. (2007) Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut 56(7): 968-973.
16. Ogawa E, Furusyo N, Toyoda K, Takeoka H, Maeda S, et al. (2009) The longitudinal quantitative assessment by transient elastography of chronic hepatitis C patients treated with pegylated interferon alpha-2b and ribavirin. Antiviral Res 83(2): 127-134.
17. Masuzaki R, Tateishi R, Yoshida H, Goto E, Sato T, et al. (2009) Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography. Hepatology. 49(6):1954-1961.
18. Wang JH, Changchien CS, Hung CH, Tung WC, Kee KM, et al. (2010) Liver stiffness decrease after effective antiviral therapy in patients with chronic hepatitis C: longitudinal study using FibroScan. J Gastroenterol Hepatol 25(5):964-969.
19. Lampertico P, Liaw YF (2012) New perspectives in the therapy of chronic hepatitis B. Gut. 61 Suppl 1: 18-24.
20. Lam YF, Yuen MF, Seto WK, Lai CL (2011) Current Antiviral Therapy of Chronic Hepatitis B: Efficacy and Safety. Curr Hepat Rep. 10(4):235-243.
21. Osakabe K, Ichino N, Nishikawa T, Sugiyama H, Kato M, et al. (2011) Reduction of liver stiffness by antiviral therapy in chronic hepatitis B. J Gastroenterol. 46(11):1324-1334
22. Wong GL, Wong VW, Choi PC, Chan AW, Chim AM, et al. (2011) On-treatment monitoring of liver fibrosis with transient elastography in chronic hepatitis B patients. Antivir Ther. 16(2):165-172.
23. Fung J, Lai CL, But D, Hsu A, Seto WK, et al. (2010) Reduction of liver stiffness following resolution of acute flares of chronic hepatitis B. Hepatol Int 4(4):716-722.
24. Hung CH, Lu SN, Wang JH, Lee CM, Chen TM, et al. (2003) Correlation between ultrasonographic and pathologic diagnoses of hepatitis B and C virus-related cirrhosis. J Gastroenterol. 38(2):153-157
25. Wang JH, Changchien CS, Hung CH, Eng HL, Tung WC, et al. (2009) FibroScan and ultrasonography in the prediction of hepatic fibrosis in patients with chronic viral hepatitis. J Gastroenterol. 44(5):439-446.
26. Hung CH, Lee CM, Lu SN (2011) Hepatitis C virus-associated insulin resistance: pathogenic mechanisms and clinical implications. Expert Rev Anti Infect Ther. 9(5):525-533.
27. Arase Y, Kobayashi M, Suzuki F, Suzuki Y, Kawamura Y, et al. (2013) Effect of type 2 diabetes on risk for malignancies includes hepatocellular carcinoma in chronic hepatitis C. Hepatology. 57(3):964-973
28. Hung CH, Lee CM, Wang JH, Hu TH, Chen CH, et al. (2011) Impact of diabetes mellitus on incidence of hepatocellular carcinoma in chronic hepatitis C patients treated with interferon-based antiviral therapy. Int J Cancer. 15:128:2344-2352.
29. Ko WH, Chiu SY, Yang KC, Chen HH (2012) Diabetes, hepatitis virus infection and hepatocellular carcinoma: A case-control study in hepatitis endemic area. Hepatol Res. 42(8):774-781.
30. Gao C, Zhao HC, Li JT, Yao SK (2010) Diabetes mellitus and hepatocellular carcinoma: comparison of Chinese patients with and without HBV-related cirrhosis. World J Gastroenterol. 16(35):4467-4475